Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print

Breaking News

Related Searches: Development CRO Phase III
April 26, 2012
Revenues drop 11%  Read More »
April 26, 2012
PRA to serve as sole provider for biosimilar studies  Read More »
April 26, 2012
Expands international presence, generic injectable business  Read More »
April 26, 2012
Revenues up 5%  Read More »
April 26, 2012
Pharmaceutical sales up 2%  Read More »
April 25, 2012
FDA to accept some studies, require reanalysis for others  Read More »
April 25, 2012
Broadens international expansion strategy  Read More »
April 25, 2012
Frontage to provide analysis, formulation and validation for AHRO-001 tablets  Read More »
April 25, 2012
Revenues up 9% in the quarter  Read More »
April 25, 2012
Zyprexa patent expirations impact results  Read More »
April 24, 2012
Eliminates 500 positions  Read More »
April 24, 2012
1Q revenues up 10%  Read More »
April 24, 2012
Enhances pMDI fill line at Northridge facility  Read More »
April 24, 2012
Will execute new marketing strategy  Read More »
April 24, 2012
Offers advanced bioprotein production   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On